Abstract:
Acute hepatopancreatic necrosis disease (AHPND) is caused by
Vibrio parahaemolyticus and is one of the most serious bacterial diseases in shrimp aquaculture. Antimicrobial peptides constitute the first line of innate immune defense in invertebrates and play essential roles in protecting against pathogen invasion. In this study, a novel crustin gene, designated SWD, was cloned and characterized from
Litopenaeus vannamei, and its role in antibacterial defense against
V.
parahaemolyticus was investigated. Its tissue distribution and pathogen-induced expression profiles were determined by quantitative real-time PCR (qPCR). RNA interference (RNAi) was used to evaluate its
in vivo function during bacterial infection. Recombinant SWD protein was expressed, purified, and subjected to bacterial-binding and antibacterial activity assays. Protective effects of SWD were further assessed in shrimp infection experiments. The results showed that SWD contained a 237 bp open reading frame encoding a 78-amino-acid peptide with a conserved whey acidic protein (WAP) domain, characteristic of type III crustins.
SWD transcripts were detected in all examined tissues and were most abundant in antenna and hemocyte. Expression of
SWD was significantly induced following stimulation with lipopolysaccharide,
V.
parahaemolyticus,
Staphylococcus aureus, and white spot syndrome virus. RNAi-mediated silencing of
SWD significantly increased bacterial loads in gill and hemocyte and reduced shrimp survival after
V.
parahaemolyticus infection. Recombinant SWD was detected in both monomeric and dimeric forms and exhibited broad bacterial-binding activity toward four Gram-negative and four Gram-positive bacterial species.
In vitro assays demonstrated that SWD inhibited the growth of
V.
parahaemolyticus in a concentration-dependent manner, with an MIC
50 value of 0.25 μmol/L. Furthermore, administration of recombinant SWD significantly decreased bacterial loads in hemocyte and improved shrimp survival following
V.
parahaemolyticus challenge. These findings expand our current knowledge of type III crustins in crustaceans and identify SWD as a potential antimicrobial candidate for the prevention and control of AHPND, providing a theoretical basis for shrimp farming disease management based on antimicrobial peptides.